Compare IMAX & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMAX | PRGO |
|---|---|---|
| Founded | 1967 | 1887 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1994 | 1991 |
| Metric | IMAX | PRGO |
|---|---|---|
| Price | $37.50 | $15.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $43.22 | $20.33 |
| AVG Volume (30 Days) | 1.3M | ★ 4.0M |
| Earning Date | 02-18-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 7.72% |
| EPS Growth | ★ 62.41 | N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | $377,677,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $17.43 | N/A |
| Revenue Next Year | $8.82 | N/A |
| P/E Ratio | $52.60 | ★ N/A |
| Revenue Growth | ★ 9.30 | N/A |
| 52 Week Low | $20.48 | $12.17 |
| 52 Week High | $39.98 | $30.93 |
| Indicator | IMAX | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 59.94 | 60.38 |
| Support Level | $33.30 | $14.60 |
| Resistance Level | $38.07 | $15.27 |
| Average True Range (ATR) | 1.07 | 0.42 |
| MACD | 0.03 | 0.16 |
| Stochastic Oscillator | 88.89 | 84.71 |
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.